Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2024

Mar 5, 2024

32485_dirs_2024-03-05_31d653c1-562c-407a-9636-b59e34fdfcc2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2024-03-01

Reporting Person: Weber Darin J. (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-01 Employee stock option (right to buy) $1.61 A 225000 Acquired 2034-03-01 Class A Ordinary Shares (225000) Direct
2024-03-01 Employee stock option (right to buy) $1.61 A 117264 Acquired 2034-03-01 Class A Ordinary Shares (117264) Direct

Footnotes

F1: The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024.

F2: The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter.